Sandoz appoints Dragos Toma to lead Egypt and Libya
By the AFREEQUE newsroom, based on Daily News Egypt
Sandoz appoints Dragos Toma to oversee its activities in Egypt and Libya, after more than 21 years in the pharmaceutical industry. He will oversee the development of generic and biosimilar medicines and access to treatments, according to Daily News Egypt.
Sandoz, the pharmaceutical group specialising in generic and biosimilar medicines, has appointed Dragos Toma as Country Head for Egypt and Libya. He has more than 21 years of experience in the pharmaceutical industry, including more than 13 years at Sandoz, according to Daily News Egypt.
Dragos Toma most recently headed Sandoz's Biosimilars and Prescription Medicines business in Romania and also served as Interim Country Head in the country. Since joining Sandoz in 2013, he has held leadership positions in oncology, transplantation, immunology, biosimilars and prescription and over-the-counter medicines, reports Daily News Egypt.
In Egypt, Sandoz says it is already present in biosimilars and has a portfolio of generic and essential medicines, while developing local manufacturing and technology transfer. Dragos Toma said he wanted to work with the group's teams, authorities and healthcare professionals to strengthen local capacities and facilitate patients' access to medicines.
His appointment comes as Sandoz seeks to expand its presence and partnerships in Egypt and Libya, according to comments by Dragos Toma reported by Daily News Egypt.
